Aging with HIV: Understanding the Journey
Join Gilead Sciences and the American Society on Aging for a series of podcast conversations about caring for older adults living with HIV.
Resource Guide: HIV/HCV Health and Housing Collaborative
HealthHIV’s HIV/HCV Health and Housing’s 2023 Resource Guide was developed throughout a year-long technical assistance project with eight organizations working to increase their HIV/HCV screening and care capacity for their clients experiencing homelessness. The resources in this document provide insight into HIV/HCV care for people experiencing homelessness in a variety of settings and with a variety of populations.
PDAB Action Steps for Patients
Patients looking to contribute to the conversation about drug affordability and Upper Payment Limits (UPLs) can start here.
PDAB: Balancing the Scale
The Role of PDABs in Drug Pricing and Healthcare Stakeholder Impacts
Considerations and Implications of PDABs and Their Impact on 340Bs
Prescription Drug Affordability Boards (PDABs) are designed to help reduce the costs of prescription medications in 11 states where they currently exist (legislation pending in 13 more states).
Prescription Drug Affordability Boards (PDABs) and Upper Payment Limits (UPLs) Impact on Patients, Drug Pricing, and Innovation
This HealthHIV Advocacy paper explores the function of Prescription Drug Affordability Boards (PDABs) in managing prescription drug costs, considering perspectives of patients, providers, and payers to ensure equitable access to vital medications while controlling healthcare expenses.
Integrating Frailty and Functional Outcomes into Clinical Trials
CROI Presentation: Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
